Skip to main content

Table 1 Medication use in patients with peripheral artery disease and controls

From: Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease

 

PAD (n = 214)

Controls (n = 197)

p-value

Aspirin (%)

65.9

54.3

0.005

Clopidogrel (%)

29.0

4.9

<0.001

Metformin (%) *

18.4

28.9

<0.001

Sulfonyrea (%) *

13.8

17.8

0.775

Glitazone (%) *

1.0

1.4

0.689

Insulin (%) *

7.9

5.1

0.211

Statins (%)

47.2

26.4

<0.001

Angiotensin Converting Enzyme Inhibitors (%)

42.5

23.4

<0.001

Calcium Antagonists (%)

31.1

9.1

<0.001

Beta Adrenoreceptor Blocking Agents (%)

37.9

44.7

0.161

Angiotensin II Receptor Blocking Agents (%)

11.2

6.1

0.067

  1. PAD denotes peripheral artery disease.
  2. * Percentage of subjects with type 2 diabetes (n = 87 and 45 in the PAD and in the control group, respectively).
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840